November 23, 2021 -- Stilla Technologies has secured 31 million euros (about $35 million) in financing in the form of convertible bonds. The new funds will be used to further develop Stilla's global commercial presence and its next-generation digital polymerase chain reaction platform, the six-color Naica system, which it recently released.
In addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement, and Eurazeo, Stilla attracted investment from life science firm Casdin Capital and the European Investment Bank.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
